Ablation of secreted phosphoprotein-1 in hepatocytes increases fatty acid oxidation and ameliorates alcohol-associated liver disease
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Osteopontin (SPP1) produced by liver cells worsens alcohol-associated liver disease (AALD) by impairing fatty acid oxidation. Reducing SPP1 in hepatocytes protects against AALD development.
Area Of Science
- Hepatology
- Molecular Biology
- Biochemistry
Background
- Osteopontin (SPP1) expression increases in hepatocytes during alcohol exposure.
- Previous studies show Spp1 knockout mice are more susceptible to alcohol-induced liver injury.
- The specific role of hepatocyte-derived SPP1 in alcohol-associated liver disease (AALD) remains unclear.
Purpose Of The Study
- To investigate the role of hepatocyte-derived SPP1 in AALD.
- To determine if SPP1 modulates steatosis in the context of AALD.
- To elucidate the molecular mechanisms by which SPP1 influences AALD progression.
Main Methods
- Analyzed hepatic SPP1 expression in human alcoholic hepatitis datasets and mouse models.
- Correlated SPP1 expression with dysregulated genes in alcoholic hepatitis.
- Utilized hepatocyte-specific Spp1 knockout mice (Spp1ΔHep) fed ethanol diets.
Main Results
- Alcohol increased hepatic SPP1 expression in humans and mice.
- SPP1 correlated with downregulated fatty acid oxidation (FAO) genes in alcoholic hepatitis.
- Spp1ΔHep mice showed reduced liver injury markers and improved FAO compared to wild-type mice.
- Hepatocytes from Spp1ΔHep mice exhibited enhanced FAO gene expression.
Conclusions
- Alcohol induces SPP1 expression in hepatocytes.
- Hepatocyte-derived SPP1 impairs fatty acid oxidation.
- SPP1 contributes to the development and progression of AALD.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
